Verified By Apollo Hospitals October 1, 2024
Niemann-Pick disease is a progressive genetic metabolic disorder that affects the body’s ability to metabolize fat within cells. It can occur at any age, but it is common in children. Although research is underway for finding suitable treatment, no complete remedy has yet been found.
It has three categories, and treatment focuses on reducing the symptoms in patients.
Request an appointment at Apollo Hospitals.
Niemann-Pick disease is a rare metabolic disorder caused by changes in the structures of specific genes. The disease is inherited only when both the parents pass on the defective gene to their child.
It usually affects children. In individuals with Niemann-Pick disease, fats and lipids accumulate in the liver, spleen, lungs, bone marrow and brain. As a result, the individual may die due to improper functioning of various body functions.
Usually, Type B occurs later in childhood and is not linked to the primary brain disease. A majority of those affected with type B survive into adulthood.
The symptoms of type A form of Niemann-Pick disease are present within the first few months of birth and include:
The signs and symptoms of the type B form of Niemann-Pick disease usually start to appear in late childhood or at the adolescence age. This form of Niemann-Pick disease does not include motor difficulty which is found commonly in type A disease. The symptoms of type B could include:
Type B form of Niemann-Pick disease differs significantly from type A form of Niemann-Pick disease which is a more serious, early-onset form of Niemann-Pick disease, in which symptoms appear in early infancy, development do not progress beyond 12 months level, and survival beyond age three is very rare.
Visit a doctor immediately if you observe any symptoms of Niemann-Pick disease developing in your child.
Request an appointment at Apollo Hospitals.
Call 1860-500-1066 to book an appointment.
Unfortunately, there is no existing cure for Type A Niemann-Pick disease.
Research is underway on using bone marrow transplants, gene therapy and enzyme replacement therapy for Type B disease.
Along with physical therapy that helps with mobility, a drug Miglustat is used to treat Type C disease. An international research study of 92 persons suffering from type C Niemann-Pick disease showed improved neurological symptoms after regularly taking miglustat for an average of two years.
Physiotherapy is a vital part of the treatment, which helps in maintaining mobility as long as possible. Individuals with Niemann-Pick disease have to see their doctors regularly, as the disease progresses and the symptoms can get worse.
Niemann-Pick disease is an inherited disease that disrupts the metabolization of fats and lipids in the body. Types A and B are common in children, while Type C commonly develops in adults. Unfortunately, it is an incurable disease, and over time, causes death . Though doctors are using some treatments to improve the symptoms, the disease does not have cure
For Types A and B: Specialists use blood or skin samples to diagnose the quantity of sphingomyelinase in the white blood cells.
For Type C: Experts take a skin sample to assess the movement of cells and how they store cholesterol.
It is a rare disorder that affects approximately 1 in 250,000 individuals.
You should consult a pediatrician if you observe your child developing any warning signs of Niemann-Pick disease .
© Copyright 2024. Apollo Hospitals Group. All Rights Reserved.